The presence of substituents on the aryl moiety of the aryl phosphoramidate derivative of d4T enhances anti-HIV efficacy in cell culture: A structure-activity relationship.
about
Synthesis of nucleoside phosphate and phosphonate prodrugsPhosphoramidate derivatives of stavudine as inhibitors of HIV: unnatural amino acids may substitute for alanine.Synthesis and antiviral activity of aryl phosphoramidate derivatives of beta-D- and beta-L-C-5-substituted 2',3'-didehydro-2',3'-dideoxy-uridine bearing linker arms.Selective intracellular activation of a novel prodrug of the human immunodeficiency virus reverse transcriptase inhibitor tenofovir leads to preferential distribution and accumulation in lymphatic tissue.Novel compounds in preclinical/early clinical development for the treatment of HIV infections.Pronucleotides: toward the in vivo delivery of antiviral and anticancer nucleotides.[d4U]-spacer-[HI-236] double-drug inhibitors of HIV-1 reverse-transcriptase.New anti-HIV agents and targets.Synthesis and biological evaluation of phosphate prodrugs of 4-phospho-D-erythronohydroxamic acid, an inhibitor of 6-phosphogluconate dehydrogenase.Antiviral activity of cyclosaligenyl prodrugs of acyclovir, carbovir and abacavir.Potent Antifouling Marine Dihydroquinolin-2(1H)-one-Containing Alkaloids from the Gorgonian Coral-Derived Fungus Scopulariopsis sp.Efficient synthesis of nucleoside aryloxy phosphoramidate prodrugs utilizing benzyloxycarbonyl protection.Practical synthesis, separation, and stereochemical assignment of the PMPA pro-drug GS-7340.Enantioselective trapping of phosphoramidate ammonium ylides with imino esters for synthesis of 2,3-diaminosuccinic acid derivatives.Phosphoramidate protides of carbocyclic 2',3'-dideoxy-2',3'-didehydro-7-deazaadenosine with potent activity against HIV and HBV.
P2860
Q26865400-C6BB66C4-F8B1-4CD4-9B34-266CFC1E5929Q31381918-FFA70C18-28B5-4C27-A793-5EFA8880B1E2Q33231478-C111EB31-4076-4CEE-AB29-CC20F700F2D8Q33769993-AB5FF50E-3920-4B9F-8EB1-52BCBA296607Q33966254-BAEEA90F-A291-4C35-858D-9EA99E839C1BQ34073753-0DB9C181-C84C-448B-97A6-4CFDF37596A6Q34242282-04D4392E-9A3D-4432-B85E-0B326E0EF0B7Q34944447-82838C08-0123-4656-AB90-ED1EEAABEC4FQ36470382-0BC8C0FE-1439-42A0-A574-6BC6535A4C5DQ40744079-6B9CE34E-D931-40BC-B22B-9AD043411BF9Q41126052-0DE29AC0-B72B-42D1-937F-60AE6B45AF0AQ42101344-71F94C8A-B62C-448A-94A6-BA03D9416946Q43741885-670E0F07-4544-4FF1-A90B-C144769A9AC8Q44735016-B17B61C0-0C30-4350-96BC-2FFCBF84E169Q45208901-7B636486-C986-47A5-9BDA-179E7230A199
P2860
The presence of substituents on the aryl moiety of the aryl phosphoramidate derivative of d4T enhances anti-HIV efficacy in cell culture: A structure-activity relationship.
description
1999 nî lūn-bûn
@nan
1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The presence of substituents o ...... ructure-activity relationship.
@ast
The presence of substituents o ...... ructure-activity relationship.
@en
type
label
The presence of substituents o ...... ructure-activity relationship.
@ast
The presence of substituents o ...... ructure-activity relationship.
@en
prefLabel
The presence of substituents o ...... ructure-activity relationship.
@ast
The presence of substituents o ...... ructure-activity relationship.
@en
P2093
P356
P1476
The presence of substituents o ...... tructure-activity relationship
@en
P2093
Balzarini J
De Clercq E
Siddiqui AQ
P304
P356
10.1021/JM9803931
P407
P577
1999-02-01T00:00:00Z